哮喘急性加重期使用β受体激动剂：多少剂量算过量？
Beta agonist use during asthma exacerbations: how much is too much?
作者信息
Patel Mitesh, Perrin Kyle, Beasley Richard
出版信息
N Z Med J. 2011 Apr 15;124(1332):77-80.
PMID:21747427
Abstract
Overuse of inhaled beta agonist therapy is associated with risk in adult asthmatics. We report on a case of excessive short-acting and long-acting beta agonist use in the setting of a severe exacerbation of asthma, which highlights some important good practice points.
摘要
吸入性β受体激动剂治疗的过度使用与成年哮喘患者的风险相关。我们报告了一例在哮喘严重加重情况下过度使用短效和长效β受体激动剂的病例，该病例突出了一些重要的良好实践要点。
Zotero 插件